GL1X · GenesisL1 explorer

MolNFT v1 · #159458 · protein

HIV-1 protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V mutant in complex with darunavir

6OPY: “HIV-1 protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V mutant in complex with…”. X-ray diffraction, 1 ligand (017), 1 pocket (best druggability 0.72). MolNFT v1 #159458 on GenesisL1: 3D structure, binding…

PDB
6OPY
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease NL4-3
UniProt
Q7SRW9
Ligands
017
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease NL4-3protein996% helix, 53% strandQ7SRW9

Ligands and binding sites

  • 017 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13820.720.8337017

Interfaces

1 interface between chains.

  • A–B · 1871 Ų buried · 34 hydrogen bonds · protein-protein

Compared structures

  • 6OPY · HIV-1 Protease NL4-3 I13V, G16E, V32I, L33F, K45I, M46I, A71V, L76V, V82F, I84V Mutant in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.